posted on 2011-05-05, 00:00authored byThomas Force, Robert O. Bonow, Steven R. Houser, R. J. Solaro, Ray E. Hershberger, Bishow Adhikari, Mark E. Anderson, Robin Boineau, Barry J. Byrne, Thomas P. Cappola, Raghu Kalluri, Martin M. LeWinter, Martin S. Maron, Jeffery D. Molkentin, Steve R. Ommen, Michael Regnier, W.H. W. Tang, Rong Tian, Marvin A. Konstam, Barry J. Maron, Christine E. Seidman
Research priorities in hypertrophic cardiomyopathy report of a working group of the national heart, lung, and blood institute
Funding
The following receive research grants from the National Institutes of Health (NIH), Howard Hughes Medical Institute (HHMI), the Fondation Leducq (FL), The American Heart Association (AHA), or other sources: Dr Force (NIH, The Kahn Foundation, the Scarperi Family, and AHA), Dr Anderson (NIH, FL), Dr Houser (NIH), Dr LeWinter (NIH), Dr Molkentin (NIH, HHMI, and FL), Dr Seidman (NIH, HHMI, and FL), Dr Solaro (NIH), Dr Byrne (NIH), Dr Maron (NIH), Dr Tang (NIH), Dr Tian (NIH), Dr Regnier (NIH), Dr Hershberger (NIH), Dr Bonow (NIH), Dr Cappola (NIH), and Dr Kalluri (NIH).
History
Publisher Statement
Post print version of article may differ from published version. The definitive version is available through American Heart Association at DOI: 10.1161/CIRCULATIONAHA.110.950089